Moderna expects Covid, RSV, flu shot sales up to $15 billion in 2027
Moderna said it sees a corresponding operating profit from its Covid, RSV, and flu vaccines in the range of $4 billion to $9 billion in 2027.
Stay updated with breaking news from Michael Yee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Moderna said it sees a corresponding operating profit from its Covid, RSV, and flu vaccines in the range of $4 billion to $9 billion in 2027.
Moderna on Tuesday said it did not collect enough data on its first experimental flu shot to predict its efficacy in a final stage study and will now advance another candidate. The biotechnology... | April 11, 2023
A look at North American equities heading in both directions
Operator: Thank you for standing by and welcome to the Invivyd 2022 Year End Financial Results Update Call. As reminder, today's call is being recorded.
Operator: Good afternoon, ladies and gentlemen, and welcome to the Ventyx Biosciences Fourth Quarter and Full Year 2022 Earnings Conference Call.